Literature DB >> 27325387

Serotonin syndrome presenting as febrile encephalopathy with CSF pleocytosis: a report of three cases.

Sanjay Prakash1, Prayag Makwana2, Chaturbhuj Rathore2, Ankit Dave2.   

Abstract

Serotonin syndrome (SS) is an iatrogenic, drug-induced clinical syndrome caused by serotoninergic hyperstimulation. SS may have protean manifestations and can mimic a variety of medical conditions. Herein, we describe three cases of febrile encephalopathy who were on serotonergic agents. All three cases fulfilled Hunter's criteria for SS and responded to the removal of the offending agents and the administration of cyproheptadine. All three patients had abnormal cerebrospinal fluid (CSF) examinations (pleocytosis in three patients and increased protein in two patients) which returned to normal with therapy. We suggest that SS presenting as febrile encephalopathy may have transient CSF abnormalities. Severe SS is a medical emergency. Therefore, a trial of cyproheptadine can be given in patients fulfilling the SS criteria even in the presence of CSF abnormalities. In parallel, the patients should be investigated for other causes of febrile encephalopathy and CSF pleocytosis.

Entities:  

Keywords:  Autonomic dysfunction; Clonus; Cyproheptadine; Serotonergic agent; Serotonin syndrome

Mesh:

Substances:

Year:  2016        PMID: 27325387     DOI: 10.1007/s10072-016-2638-2

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  7 in total

1.  The Hunter Serotonin Toxicity Criteria: simple and accurate diagnostic decision rules for serotonin toxicity.

Authors:  E J C Dunkley; G K Isbister; D Sibbritt; A H Dawson; I M Whyte
Journal:  QJM       Date:  2003-09

Review 2.  The serotonin syndrome.

Authors:  Edward W Boyer; Michael Shannon
Journal:  N Engl J Med       Date:  2005-03-17       Impact factor: 91.245

3.  Febrile encephalopathy: challenges in management.

Authors:  M E Yeolekar; T H Trivedi
Journal:  J Assoc Physicians India       Date:  2006-11

4.  An exploratory approach to the serotonin syndrome: an update of clinical phenomenology and revised diagnostic criteria.

Authors:  J W Radomski; S M Dursun; M A Reveley; S P Kutcher
Journal:  Med Hypotheses       Date:  2000-09       Impact factor: 1.538

5.  5-Hydroxytryptamine receptor characterization of human cerebral, middle meningeal and temporal arteries: regional differences.

Authors:  I Jansen; J Olesen; L Edvinsson
Journal:  Acta Physiol Scand       Date:  1993-02

6.  5-hydroxytryptamine(2A) receptors regulate sympathetic nerves constricting the cutaneous vascular bed in rabbits and rats.

Authors:  W W Blessing; B Seaman
Journal:  Neuroscience       Date:  2003       Impact factor: 3.590

7.  Mild serotonin syndrome: A report of 12 cases.

Authors:  Sanjay Prakash; Varsha Patel; Siddharth Kakked; Indravadan Patel; Rahul Yadav
Journal:  Ann Indian Acad Neurol       Date:  2015 Apr-Jun       Impact factor: 1.383

  7 in total
  1 in total

1.  Refining the Clinical Features of Serotonin Syndrome: A Prospective Observational Study of 45 Patients.

Authors:  Sanjay Prakash; Chaturbhuj Rathore; Kaushik Kumar Rana; Ankit Dave; Hemant Joshi; Jay Patel
Journal:  Ann Indian Acad Neurol       Date:  2019 Jan-Mar       Impact factor: 1.383

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.